Nightingale AI is developing Trialbird - AI agents to speed up & personalize patient recruitment, simplify paperwork and save time for study personnel.

#ClinicalTrials #AIHealthcare #MedTech

What our founder think:

We are impacting the world by….

speeding up the development of new medicines and medical devices to benefit millions of patients.

We are convinced that the world in the next 5 years …

will see AI revolutionize healthcare for the benefit of patients, providers and other stakeholders.

REAKTOR.BERLIN enables us to…

get great feedback and mentoring, enjoy the founder community and learn business.

About:

Clinical Trials are necessary to develop safe and effective medications. A clinical trial costs a pharma company around 19 million, where patient recruitment is the largest cost driver. Still, more than half of planned clinical trials are cancelled because they can’t find the patients. Meanwhile, lead study doctors are getting rare as many doctors leave the clinical research field because of high bureaucratic burden. Nightingale AI is developing Trialbird – specialised AI agents to improve clinical trials. For example, an AI agent can take time to convince patients of trial participation and personalize the onboarding. Alternatively, an AI can help ease the bureaucratic burden for personnel: Conducting literature research for grant applications, creating study protocols or writing final study reports. We are Chiara, an IT and product management specialist, and Nils, a medical doctor with a great clinical network. Let’s transform clinical research together!

Founder team

Industry

Healthcare

Find out more

tio health

Investieren Sie in
die Zukunft der Kinderheilkunde

Werden Sie Teil von tio – einer digitalen Plattform, die Eltern Orientierung gibt und Kinderarztpraxen entlastet. Sie können sich bereits mit kleineren Beträgen beteiligen – auch ohne Erfahrung mit Startup-Investments.